Zobrazeno 1 - 7
of 7
pro vyhledávání: '"J M Fernandez Ranada"'
Autor:
F. Rodriguez Salvanés, P. Martín-Regueira, R de la Cámara, Felipe Casado, Maria José Requena, J. M. Fernandez Ranada, Juan Luis Steegmann
Publikováno v:
American Journal of Hematology. 72:170-176
Interferon-alpha is the frontline therapy of the majority of chronic myeloid leukemia (CML) patients who are not eligible for bone marrow transplantation. Many patients are treated for long periods, and there is concern about the long-term immune eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53fbb75556e1b6c384045117b0171b96
https://doi.org/10.1002/ajh.10282
https://doi.org/10.1002/ajh.10282
Autor:
A. T. Tamayo, J. M. Fernandez-Ranada, Jose Francisco Tomas, C. Martinez-Chamorro, Reyes Arranz, J J Gil-Fernández, C. Ramos, A. Figuera
Publikováno v:
Annals of Hematology. 82:14-18
Nowadays, the chemoradiotherapeutic protocols for Hodgkin's disease (HD) achieve high curability rates. Hemato-oncologists focus on both avoiding medical and psychological sequelae of the treatment and returning patients to a normal life. The quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::995b066a48a67c988d280910a5b3443a
https://doi.org/10.1007/s00277-002-0582-0
https://doi.org/10.1007/s00277-002-0582-0
Autor:
J. M. Fernandez-Ranada, Adrian Alegre, J F Tomas, Agustín Acevedo, R Arranz, J J Gil-Fernández
Publikováno v:
Journal of Clinical Pathology. 49:512-514
Gelatinous degeneration of marrow is a rare histological disorder associated with chronic debilitating diseases, such as anorexia nervosa, AIDS and postchemotherapy aplasia. Solid tumours have been associated with this condition but it has been repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6884e4f0dc6542c081e278dc1fc11d
https://doi.org/10.1136/jcp.49.6.512
https://doi.org/10.1136/jcp.49.6.512
Autor:
C Nichols, C F LeMaistre, A Smith, M Lange, J. E. Anderson, J M Fernandez Ranada, Julie M. Vose, W Longo, L. Garrison, E A Copelan, A Granena, A N Pandite, D L Topolsky, T Ahmed, R. B. Geller, I Tabbara, P. J. Bierman, Patrick J. Stiff, M W Schuster, R A Beveridge, M. E. Lebsack, A. Keating
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 15(4)
PURPOSE A phase III trial to compare PIXY321 with granulocyte-macrophage colony-stimulating factor (GM-CSF) following high-dose therapy and autologous bone marrow transplant (ABMT) was conducted to evaluate the time to hematopoietic recovery. PATIENT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8efccef669779463619c68ef961455b
https://pubmed.ncbi.nlm.nih.gov/9193361
https://pubmed.ncbi.nlm.nih.gov/9193361
Autor:
C. Varela, Felix Carbonell, Pilar Giraldo, J. Gómez Codina, M. Provencio, Eulogio Conde, E. Rios, Antonio Rueda, J M Fernandez Ranada, Francisco Javier Capote
Publikováno v:
Journal of Clinical Oncology. 25:8092-8092
8092 Background: In patients with relapsed or refractory follicular lymphoma (FL) who attain a response with either cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) alone or Rituximab + CHOP, maintenance treatment with Rituximab has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a4a1dac6a9ba61b0cfb8e7863ff4e9d
https://doi.org/10.1200/jco.2007.25.18_suppl.8092
https://doi.org/10.1200/jco.2007.25.18_suppl.8092
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.